Steven F. Mayer serves as Executive at Talecris Biotherapeutics Holdings Corp., where they oversee executive responsibilities. Since joining the company, Steven F. Mayer has executed 11 insider transactions totaling $103.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 19, 2026 involved purchasing 69,000 shares valued at $36.6K.
Steven F. Mayer currently holds 1,490,745 shares of Talecris Biotherapeutics Holdings Corp. (TLCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven F. Mayer has been a net buyer of TLCR stock. They have purchased $103.8K and sold $0 worth of shares.
Steven F. Mayer's most recent insider trade was on Feb 19, 2026, when they purchased 69,000 shares at $0.53 per share.
Get notified when new Form 4 filings are submitted
| $0.53 |
| Discretionary |
| Nov 28, 2025 | ARAY | $0 | Award | 895,391 | $N/A | Discretionary |
| Nov 21, 2025 | ARAY | $0 | Option Exercise | 45,620 | $N/A | Discretionary |
| Oct 31, 2025 | ARAY | $0 | Award | 354,609 | $N/A | Discretionary |
| May 31, 2019 | KN | $0 | Award | 10,808 | $N/A | Discretionary |
| May 31, 2019 | KN | $0 | Award | 17,166 | $N/A | Discretionary |
| May 9, 2017 | AVP | $115.6K | Disposition | 32,659 | $3.54 | Discretionary |
| May 9, 2017 | AVP | $0 | Option Exercise | 32,659 | $N/A | Discretionary |
| Jun 1, 2011 | TLCR | $0 | Disposition | 3,019 | $N/A | Discretionary |
| Apr 1, 2010 | TLCR | $0 | Award | 3,019 | $N/A | Discretionary |